How to Get Cometriq (Cabozantinib) Covered by Blue Cross Blue Shield Michigan: Complete Guide to Prior Authorization, Appeals, and Coding
Answer Box: Getting Cometriq Covered by BCBS Michigan
Cometriq (cabozantinib) is covered by Blue Cross Blue Shield of Michigan with prior authorization for metastatic medullary thyroid carcinoma. Key requirements: ICD-10 code C73, documented MTC diagnosis, and electronic PA submission via CoverMyMeds or similar platform. If denied, you have 127 days